Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis.

Advances in therapy - 1 Apr 2022

Olson Amy L, Hartmann Nadine, Patnaik Padmaja, Garry Elizabeth M, Bohn Rhonda L, Singer David, Baldwin Michael, Wallace Laura

Abstract excerpt

INTRODUCTION: We aimed to describe healthcare resource utilization (HCRU) patterns and costs in patients with fibrosing interstitial lung disease (ILD) and those with a progressive phenotype of fibrosing ILD in a US claims database. METHODS: Data from the IBM® MarketScan® databases (1 October 2011-30 September 2015) were used. Diagnosis codes documented on medical claims on two occasions (without any claims...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to Idiopathic Pulmonary Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Diseases, Interstitial

Share to Patient Acceptance of Health Care

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 35199282
DOI: 10.1007/s12325-022-02066-9
PMCID: PMC8990938

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis.PMID 35199282Read ↗

Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.Semantic proximity Read ↗

Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype.Semantic proximity Read ↗

The burden of Progressive Fibrotic Interstitial lung disease across the UKSemantic proximity Read ↗

Current monitoring and treatment of progressive fibrosing interstitial lung disease: a survey of physicians in Japan, the United States, and the European Union.Semantic proximity Read ↗

An IPF-like disease course in disorders other than IPF: how can this be anticipated, recognized, and managed?Semantic proximity Read ↗

Treatment patterns and patient journey in progressive pulmonary fibrosis: a cross-sectional surveySemantic proximity Read ↗

Progressive fibrosing interstitial lung disease: prevalence and clinical outcome.Semantic proximity Read ↗

Idiopathic pulmonary fibrosis: phenotypes and comorbidities.Semantic proximity Read ↗

Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype.Semantic proximity Read ↗

A syndromic framework for progressive pulmonary fibrosis.Semantic proximity Read ↗

Comorbidities in Unclassifiable Interstitial Lung DiseaseSemantic proximity Read ↗

Clinical Scope and Healthcare Utilization in Childhood Interstitial Lung Disease at a Tertiary CenterSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.